Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebral Blood Flow following TNF-alpha Antagonism in Rheumatoid Arthritis
2006-006127-40Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Dec 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in rheumatoid arthritis (RA), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Change in cerebral blood flow between week 0 and week 12. Started Dec 2006; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-006127-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006127-40.